BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9458619)

  • 1. Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus.
    Buyon JP
    J Am Med Womens Assoc (1972); 1998; 53(1):13-7. PubMed ID: 9458619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen therapy in systemic lupus erythematosus.
    Askanase AD
    Treat Endocrinol; 2004; 3(1):19-26. PubMed ID: 15743110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.
    Buyon JP; Petri MA; Kim MY; Kalunian KC; Grossman J; Hahn BH; Merrill JT; Sammaritano L; Lockshin M; Alarcón GS; Manzi S; Belmont HM; Askanase AD; Sigler L; Dooley MA; Von Feldt J; McCune WJ; Friedman A; Wachs J; Cronin M; Hearth-Holmes M; Tan M; Licciardi F
    Ann Intern Med; 2005 Jun; 142(12 Pt 1):953-62. PubMed ID: 15968009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen use in systemic lupus erythematosus].
    Ketari S; Cherif O; Boussema F; Kochbati S; Ben Dhaou B; Rokbani L
    Gynecol Obstet Fertil; 2005 Oct; 33(10):783-90. PubMed ID: 16139552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of exogenous estrogens in systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    Semin Arthritis Rheum; 2001 Jun; 30(6):426-35. PubMed ID: 11404826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.
    Mok CC; Ying SK; Ma KM; Wong CK
    Lupus; 2013 Dec; 22(14):1470-8. PubMed ID: 24113197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
    Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
    Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
    Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives in women with systemic lupus erythematosus.
    Buyon JP
    Ann Med Interne (Paris); 1996; 147(4):259-64. PubMed ID: 8952745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
    Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA
    Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease.
    Hochman J; Urowitz MB; Ibañez D; Gladman DD
    Lupus; 2009 Apr; 18(4):313-7. PubMed ID: 19276299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus.
    Holroyd CR; Edwards CJ
    Climacteric; 2009 Oct; 12(5):378-86. PubMed ID: 19591008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A; Piette JC
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.
    Mok CC; To CH; Mak A; Ma KM
    Arthritis Rheum; 2005 Dec; 52(12):3997-4002. PubMed ID: 16320346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus.
    Mok CC; Lau CS; Ho CT; Lee KW; Mok MY; Wong RW
    Scand J Rheumatol; 1998; 27(5):342-6. PubMed ID: 9808396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopause hormonal therapy in women with systemic lupus erythematosus.
    Sánchez-Guerrero J; González-Pérez M; Durand-Carbajal M; Lara-Reyes P; Jiménez-Santana L; Romero-Díaz J; Cravioto MD
    Arthritis Rheum; 2007 Sep; 56(9):3070-9. PubMed ID: 17763408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal therapy in systemic lupus erythematosus].
    Kaliterna DM; Krstulović DM; Radić M
    Reumatizam; 2009; 56(2):41-3. PubMed ID: 20429261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE).
    Arden NK; Lloyd ME; Spector TD; Hughes GR
    Lupus; 1994 Feb; 3(1):11-3. PubMed ID: 8025579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy.
    Petri M
    Lupus; 2001; 10(3):222-6. PubMed ID: 11315357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus.
    Meier CR; Sturkenboom MC; Cohen AS; Jick H
    J Rheumatol; 1998 Aug; 25(8):1515-9. PubMed ID: 9712093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.